As a triterpenoid, Celastrol has been reported to suppress NF-κB/MAPK inflammatory signaling and activate the Nrf2/HO-1 antioxidant pathway in sepsis-induced lung injury, thereby reducing inflammation, inhibiting apoptosis, and improving lung function (33–35). The gene discussed is NFKB1; the disease is Sepsis.